IDDF2024-ABS-0270 Efficacy and Safety of Bulevirtide in Combination with Pegylated Interferon Alfa-2A in Patients with Chronic Hepatitis Delta: Primary Endpoint Results from a Phase 2b Open-Label, Randomized, Multicenter Study MYR204 Jacques Yu,Tarik Asselah,Pietro Lampertico,Heiner Wedemeyer,Adrian Streinu-Cercel,Victor Pantea,Stefan Lazar,Gheorghe Placinta,George Gherlan,Pavel Bogomolov,Tatyana Stepanova,Viacheslav Morozov,Vladimir Chulanov,Vladimir Syutkin,Olga Sagalova,Vladimir Gorodin,Dmitry Manuilov,Renee-Claude Mercier,Lei Ye,John Flaherty,Anu OsinusI,Audrey Lau,Ben Da,Marc Bourliere,Vlad Ratziu, Stanilas Pol,Marie-Noëlle Hilleret,Fabien ZoulimClinical Hepatology（2024）引用 0|浏览1AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
